Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$153.94 - $174.85 $69,273 - $78,682
-450 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$79.39 - $115.35 $31,756 - $46,140
-400 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$78.31 - $95.34 $31,324 - $38,136
400 New
400 $35,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.7B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Nwk Group, Inc. Portfolio

Follow Nwk Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwk Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nwk Group, Inc. with notifications on news.